PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
3.42%
Some net income increase while MCHP is negative at -52.76%. John Neff would see a short-term edge over the struggling competitor.
1.87%
D&A growth well above MCHP's 2.26%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
46.15%
Some yoy growth while MCHP is negative at -45.06%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
No Data
No Data available this quarter, please select a different quarter.
79.32%
Slight usage while MCHP is negative at -267.93%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
100.00%
AR growth of 100.00% while MCHP is zero at 0.00%. Bruce Berkowitz would see a mild difference in credit approach that could matter for cash flow.
-28.26%
Both reduce yoy inventory, with MCHP at -174.73%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
100.00%
AP growth of 100.00% while MCHP is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might matter for short-term liquidity if expansions are large.
237.84%
Some yoy usage while MCHP is negative at -199.36%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
-219.05%
Negative yoy while MCHP is 121.89%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
92.86%
Some CFO growth while MCHP is negative at -19.65%. John Neff would note a short-term liquidity lead over the competitor.
-22.73%
Negative yoy CapEx while MCHP is 33.29%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
-1.22%
Negative yoy purchasing while MCHP stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-18.70%
We reduce yoy sales while MCHP is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
No Data
No Data available this quarter, please select a different quarter.
-8900.00%
Both yoy lines negative, with MCHP at -165.17%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
100.00%
Debt repayment growth of 100.00% while MCHP is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
193.75%
Issuance growth of 193.75% while MCHP is zero at 0.00%. Bruce Berkowitz sees a mild dilution that must be justified by expansions or acquisitions vs. competitor’s stable share base.
-27.08%
We cut yoy buybacks while MCHP is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.